NovoBind

NovoBind is an integrated animal health company developing biologics to combat rising resistance to anti-infectives in livestock, aquaculture and pets. Antimicrobial resistance threatens the sustainability of our food sources worldwide. NovoBinds solutions are based on their single-domain antibodies that target and neutralize pathogens safely in a specific, sustainable and economical manner. The single-domain antibodies can be produced using well-characterized host organisms or delivered safely via live probiotics that directly produce and secrete the antibodies into the gastro-intestinal tract of the host. NovoBind’s portfolio is completely proprietary with patents for major hosts including Salmonella in chickens and Parvovirus in dogs.

Jobs: